Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS

被引:106
作者
Ding, QX [1 ]
Dimayuga, E [1 ]
Keller, JN [1 ]
机构
[1] Univ Kentucky, Dept Anat & Neurobiol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
关键词
D O I
10.1089/ars.2006.8.163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteasome-mediated protein degradation is responsible for a large percentage of bulk protein turnover, particularly the degradation of short-lived and oxidized proteins. Increasing evidence suggests that proteasome inhibition occurs during the aging of the central nervous system (CNS), and in a variety of age-related disorders of the CNS. The focus of this review is to discuss the role of the proteasome as a regulator of oxidative stress, with preservation of proteasome function playing an important role in preventing oxidative stress, and proteasome inhibition playing an important role as a mediator of oxidative stress. In particular, this review will describe experimental evidence that proteasome inhibition is sufficient to induce mitochondrial dysfunction, increase reactive oxygen species generation, elevate RNA and DNA oxidation, and promote protein oxidation. Taken together, these data indicate that the proteasome is an important regulator of oxidative damage in the CNS, and suggest that proteasome inhibition may serve as an important switch for the induction of oxidative stress in the CNS. Additionally we discuss the likelihood that the 20S proteasome and 26S proteasome may play different roles in regulating oxidative stress and neurotoxicity in the aging CNS, and in age-related disorders of the CNS.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 101 条
[31]   Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins [J].
Ding, QX ;
Keller, JN .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (04) :1010-1017
[32]   Proteasomes and proteasome inhibition in the central nervous system [J].
Ding, QX ;
Keller, JN .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (05) :574-584
[33]   Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome [J].
Elsasser, S ;
Chandler-Militello, D ;
Müller, B ;
Hanna, J ;
Finley, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :26817-26822
[34]   CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].
ESTERBAUER, H ;
SCHAUR, RJ ;
ZOLLNER, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128
[35]   Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal [J].
Ferrington, DA ;
Kapphahn, RJ .
FEBS LETTERS, 2004, 578 (03) :217-223
[36]   Oxidative stress in brain aging - Implications for therapeutics of neurodegenerative diseases [J].
Floyd, RA ;
Hensley, K .
NEUROBIOLOGY OF AGING, 2002, 23 (05) :795-807
[37]   Proteasome inhibitor PS-341 induces a apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells [J].
Fribley, A ;
Zeng, QH ;
Wang, CY .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (22) :9695-9704
[38]   Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein [J].
Friguet, B ;
Szweda, LI .
FEBS LETTERS, 1997, 405 (01) :21-25
[39]   The budding yeast, Saccharomyces cerevisiae, as a model for aging research:: a critical review [J].
Gershon, H ;
Gershon, D .
MECHANISMS OF AGEING AND DEVELOPMENT, 2000, 120 (1-3) :1-22
[40]   The regulatory particle of the Saccharomyces cerevisiae proteasome [J].
Glickman, MH ;
Rubin, DM ;
Fried, VA ;
Finley, D .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (06) :3149-3162